The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
Moist wound dressing for chronic wound treatment now available in Germany
Approval to dramatically change CAR-T therapies landscape
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Subscribe To Our Newsletter & Stay Updated
